Skip to main content
SpringerLink
Log in
Book cover

miRNAs and Target Genes in Breast Cancer Metastasis pp 53–64Cite as

Clinical Perspectives: Breast Cancer Bone Metastasis

  • Chapter
  • First Online:

  • 621 Accesses

Part of the book series: SpringerBriefs in Cancer Research ((BRIEFSCANCER))

Abstract

Bone metastasis of breast cancer denotes progression of the disease process resulting in increased morbidity and a decrease in quality of life. Early diagnosis and treatment may help minimize pain and improve function. Metastatic lesions from the breast are commonly osteolytic but may be osteoblastic or mixed in nature and are mediated by the RANKL or endothelin1 pathway. The spine and proximal femur are the commonest sites of involvement. Patients are often in pain which is made worse by pathological fractures. Spinal cord compression may occur in vertebral fractures with the presence of neurological deficits. A complete workup is essential to delineate the metastatic lesion and determine the structural integrity of the pathological site. Bisphosphonates decrease osteoclastic activity and are administered to delay or prevent skeletal events. Indications for surgical management of metastatic bone disease include impending fractures, pathologic fractures of long bones and pelvis, untreatable bone pain, instability, and spinal cord compression. Spinal decompression and stabilization is indicated if the metastatic lesion is accompanied with weakness in the extremities. Impending or complete fractures of the long bones will necessitate internal fixation permitting early mobilization and pain relief. Surgical treatment of bone metastasis has not been reported to improve survival.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wegener B, Schlemmer M, Stemmler J, Jansson V, Dürr HR, Pietschmann MF (2012) Analysis of orthopedic surgery of bone metastases in breast cancer patients. BMC Musculoskelet Disord 13:232. doi:10.1186/1471-2474-13-232

    Article  PubMed  PubMed Central  Google Scholar 

  2. Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA (2013) Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. J Bone Joint Surg Am 95(20):1887–1895, Review

    PubMed  Google Scholar 

  3. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2013) Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. doi:10.1002/cncr.28509, Epub ahead of print

    Google Scholar 

  4. Azim H, Azim HA Jr (2013) Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther 13(2):195–201. doi:10.1586/era.12.177, Review

    Article  PubMed  CAS  Google Scholar 

  5. Greco C, Forte L, Erba P, Mariani G (2011) Bone metastases, general and clinical issues. Q J Nucl Med Mol Imaging 55(4):337–352

    PubMed  CAS  Google Scholar 

  6. Ibrahim T, Farolfi A, Mercatali L, Ricci M, Amadori D (2013) Metastatic bone disease in the era of bone-targeted therapy: clinical impact. Tumori 99(1):1–9

    PubMed  CAS  Google Scholar 

  7. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243–6249

    Article  Google Scholar 

  8. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55(1):61–66

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Hill ME, Richards MA, Gregory WM, Smith P, Rubens RD (1993) Spinal cord compression in breast cancer: a review of 70 cases. Br J Cancer 68(5):969–973

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572, Review

    Article  PubMed  CAS  Google Scholar 

  11. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3(6):537–549

    Article  PubMed  CAS  Google Scholar 

  12. Jezierska A, Motyl T (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15(2):RA32–RA40, Review

    PubMed  CAS  Google Scholar 

  13. Cabioglu N, Sahin AA, Morandi P, Meric-Bernstam F, Islam R, Lin HY, Bucana CD, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M (2009) Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications. Ann Oncol 20(6):1013–1019. doi:10.1093/annonc/mdn740, Epub 2009 Feb 23

    Article  PubMed  CAS  Google Scholar 

  14. Soria G, Ben-Baruch A (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267(2):271–285. doi:10.1016/j.canlet.2008.03.018, Epub 2008 Apr 24. Review

    Article  PubMed  CAS  Google Scholar 

  15. Harvey HA (1997) Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma. Cancer 80(8 Suppl):1646–1651, Review

    Article  PubMed  CAS  Google Scholar 

  16. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350(16):1655–1664, Review

    Article  PubMed  CAS  Google Scholar 

  17. Clines GA, Guise TA (2008) Molecular mechanisms and treatment of bone metastasis. Expert Rev Mol Med 10:e7. doi:10.1017/S1462399408000616, Review

    Article  PubMed  Google Scholar 

  18. Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12(20 Pt 2):6213s–6216s, Review

    Article  PubMed  CAS  Google Scholar 

  19. Elston CW, Blamey RW, Johnson J, Bishop HM, Haybittle JL, Griffiths K (1980) The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. Eur J Cancer (Suppl 1):59–62

    Google Scholar 

  20. Lee YT (1985) Biochemical and hematological tests in patients with breast carcinoma: correlations with extent of disease, sites of relapse, and prognosis. J Surg Oncol 29(4):242–248

    Article  PubMed  CAS  Google Scholar 

  21. Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12(20 Pt 2):6222s–6230s, Review

    Article  PubMed  CAS  Google Scholar 

  22. Wong M, Pavlakis N (2011) Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) 3:35–60, eCollection 2011. Review

    Google Scholar 

  23. Pavlakis N, Schmidt R, Stockler M (2005) Bisphosphonates for breast cancer. Cochrane Database Syst Rev (3):CD003474. Review

    Google Scholar 

  24. Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann JS, Bosserman LD, Geoghegan C, Hillner BE, Theriault RL, Zuckerman DS, Von Roenn JH, American Society of Clinical Oncology (2011) American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol 29(9):1221–1227. doi:10.1200/JCO.2010.32.5209, Epub 2011 Feb 22. Erratum in: J Clin Oncol. 2011 Jun 1;29(16):2293

    Article  PubMed  Google Scholar 

  25. Hoskin PJ (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev 29(4):321–327, Review

    Article  PubMed  CAS  Google Scholar 

  26. Alvi HM, Damron TA (2013) Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone? Clin Orthop Relat Res 471(3):706–714

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res (249):256–264

    Google Scholar 

  28. Piccioli A, Rossi B, Scaramuzzo L, Spinelli MS, Yang Z, Maccauro G (2014) Intramedullary nailing for treatment of pathologic femoral fractures due to metastases. Injury 45(2):412–417. doi:10.1016/j.injury.2013.09.025, Epub 2013 Sep 19

    Article  PubMed  Google Scholar 

  29. Piccioli A, Maccauro G, Rossi B, Scaramuzzo L, Frenos F, Capanna R (2010) Surgical treatment of pathologic fractures of humerus. Injury 41(11):1112–1116. doi:10.1016/j.injury.2010.08.015, Epub 2010 Sep 9

    Article  PubMed  Google Scholar 

  30. Weber KL, Lewis VO, Randall RL, Lee AK, Springfield D (2004) An approach to the management of the patient with metastatic bone disease. Instr Course Lect 53:663–676, Review

    PubMed  Google Scholar 

  31. Harrington KD (1986) Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect 35:357–381

    PubMed  CAS  Google Scholar 

  32. Ward WG, Spang J, Howe D, Gordan S (2000) Femoral recon nails for metastatic disease: indications, technique, and results. Am J Orthop (Belle Mead NJ) 29(9 Suppl):34–42

    CAS  Google Scholar 

  33. Damron TA, Sim FH (2000) Surgical treatment for metastatic disease of the pelvis and the proximal end of the femur. Instr Course Lect 49:461–470, Review

    PubMed  CAS  Google Scholar 

  34. Klimo P Jr, Kestle JR, Schmidt MH (2003) Treatment of metastatic spinal epidural disease: a review of the literature. Neurosurg Focus 15(5):E1, Review

    Article  PubMed  Google Scholar 

  35. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648

    Article  PubMed  Google Scholar 

  36. McNeil BJ (1984) Value of bone scanning in neoplastic disease. Semin Nucl Med 14(4):277–286, Review

    Article  PubMed  CAS  Google Scholar 

  37. Hagiwara M, Delea TE, Chung K (2014) Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases. J Med Econ 17(3):223–230. doi:10.3111/13696998.2014.890937

    Article  PubMed  Google Scholar 

  38. Dürr HR, Müller PE, Lenz T, Baur A, Jansson V, Refior HJ (2002) Surgical treatment of bone metastases in patients with breast cancer. Clin Orthop Relat Res 396:191–196

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Detroit Receiving Hospital, UHC Suite 4G, 4201 St Antoine Blvd, Detroit, MI, 48201, USA

    Allen Kadado, Anil Sethi & Rahul Vaidya

  2. Karmanos Cancer Institute, Detroit, MI, USA

    Rahul Vaidya

Authors
  1. Allen Kadado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anil Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rahul Vaidya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anil Sethi .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kadado, A., Sethi, A., Vaidya, R. (2014). Clinical Perspectives: Breast Cancer Bone Metastasis. In: miRNAs and Target Genes in Breast Cancer Metastasis. SpringerBriefs in Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-08162-5_5

Download citation

Publish with us

Policies and ethics

Search

Navigation